Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Novel therapies to achieve the recommended low-density lipoprotein cholesterol concentration (LDL-C) targets for patients after coronary artery bypass grafting

Journal of Thoracic and Cardiovascular Surgery(2023)10.1016/j.jtcvs.2023.05.028Source: DataRank Database

Novel therapies to achieve the recommended low-density lipoprotein cholesterol concentration (LDL-C) targets for patients after coronary artery bypass grafting is a research paper published in Journal of Thoracic and Cardiovascular Surgery (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.02)OA: bronzeTopics (34)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Sadeer Al‐Kindi ORCID,Salim S. Virani ORCID,Stephen E. Fremes ORCID,Salil V. Deo ORCID

Live enrichment

PubMed:37286075 OpenAlex:https://openalex.org/W4379380894

American College of Cardiology Foundation

National Institutes of Health

U.S. Department of Veterans Affairs

FWCI

1.02

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.jtcvs.org/article/S002252232300452X/pdf

publisherhttp://www.jtcvs.org/article/S002252232300452X/pdf

publisherhttps://api.elsevier.com/content/article/PII:S002252232300452X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S002252232300452X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jtcvs.2023.05.028

Fields of Study

Lipoproteins and Cardiovascular HealthCardiac, Anesthesia and Surgical OutcomesCardiac Valve Diseases and TreatmentsHumansCholesterol, LDLAnticholesteremic AgentsHypercholesterolemiaCoronary Artery BypassHydroxymethylglutaryl-CoA Reductase Inhibitors

MeSH Terms

Anticholesteremic AgentsCoronary Artery BypassHumansHypercholesterolemiaCholesterol, LDLHydroxymethylglutaryl-CoA Reductase Inhibitors

Keywords

MedicineBypass graftingArteryLdl cholesterolMedical therapyInternal medicineCholesterolCardiologyIntensive care medicineSurgeryAtherosclerosiscoronary artery diseaseEzetimibeCoronary Artery Bypass GraftingStatin IntoleranceStatin-associated Muscle SymptomsBempedoic AcidInclisiranPsck9 Inhibitor

Sustainable Development Goals

SDG 0: Good health and well-being